{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T08:01:40Z","timestamp":1795161700331,"version":"4.10.3"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>Accumulated data support a relationship between mood disorders and cellular plasticity and resilience, some suggesting relevance to autophagy. Our previous data show that pharmacological enhancement of autophagy results in antidepressant-like effects in mice. The current study was designed to further examine the effects of autophagy enhancement on mood by testing the effects of subchronic treatment with the mammalian target of rapamycin (mTOR) inhibitors and autophagy enhancers rapamycin and temsirolimus in a model for mania and in a model for antidepressant action, respectively. The results show that rapamycin reduced mania-like aggression and reward-seeking behaviors, with no effects on locomotion. Temsirolimus reduced depression-related immobility in the forced-swim test without effects on locomotion in the open field or on anxiety-related measures in the elevated plus maze. Taken together with our previous findings, these data support the notion that enhancing autophagy may have mood-stabilizing effects.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000334","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T22:47:24Z","timestamp":1501714044000},"page":"379-384","source":"Crossref","is-referenced-by-count":50,"title":["Mood-stabilizing effects of rapamycin and its analog temsirolimus: relevance to autophagy"],"prefix":"10.1097","volume":"29","author":[{"given":"Nirit Z.","family":"Kara","sequence":"first","affiliation":[{"name":"School of Behavioral Sciences, Tel Aviv-Yaffo Academic College, Tel Aviv, Israel"},{"name":"Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomit","family":"Flaisher-Grinberg","sequence":"additional","affiliation":[{"name":"Department of Psychology, Saint Francis University, Loretto, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant W.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galila","family":"Agam","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Einat","sequence":"additional","affiliation":[{"name":"School of Behavioral Sciences, Tel Aviv-Yaffo Academic College, Tel Aviv, Israel"},{"name":"Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheba, Israel"},{"name":"Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"R2-20240213","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1053\/j.seminoncol.2009.10.009","article-title":"Intravenous temsirolimus in cancer patients: clinical pharmacology and dosing considerations","volume":"36","author":"Boni","year":"2009","journal-title":"Semin Oncol"},{"key":"R3-20240213","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1517\/14740338.2012.713344","article-title":"Temsirolimus: a safety and efficacy review","volume":"11","author":"Bukowski","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"R4-20240213","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1200\/JCO.2005.66.130","article-title":"Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer","volume":"23","author":"Chan","year":"2005","journal-title":"J Clin Oncol"},{"key":"R5-20240213","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.brainresbull.2008.03.005","article-title":"Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders","volume":"76","author":"Cleary","year":"2008","journal-title":"Brain Res Bull"},{"key":"R6-20240213","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/ijc.25477","article-title":"The antidepressants maprotiline and fluoxetine induce type II autophagic cell death in drug-resistant Burkitt\u2019s lymphoma","volume":"128","author":"Cloonan","year":"2011","journal-title":"Int J Cancer"},{"key":"R7-20240213","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10519-006-9093-4","article-title":"Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease","volume":"37","author":"Einat","year":"2007","journal-title":"Behav Genet"},{"key":"R8-20240213","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.biopsych.2005.11.004","article-title":"Cellular plasticity cascades: gene to behavior pathways in animal models of bipolar disorder","volume":"59","author":"Einat","year":"2006","journal-title":"Biological Psychiatry"},{"key":"R9-20240213","first-page":"14","article-title":"The effects of the atypical antipsychotic asenapine in a strain-specific battery of tests for mania-like behaviors","volume":"14","author":"Ene","year":"2015","journal-title":"Behav Pharmacol"},{"key":"R10-20240213","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000381785","article-title":"Introducing female Black Swiss mice: minimal effects of sex in a strain-specific battery of tests for mania-like behavior and response to lithium","volume":"95","author":"Ene","year":"2015","journal-title":"Pharmacology"},{"key":"R11-20240213","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr Clin North Am"},{"key":"R12-20240213","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneumeth.2008.09.018","article-title":"Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania","volume":"177","author":"Flaisher-Grinberg","year":"2009","journal-title":"J Neurosci Methods"},{"key":"R13-20240213","first-page":"1","article-title":"Strain Specific battery of tests for separate behavioral domains of mania","volume":"1","author":"Flaisher-Grinberg","year":"2010","journal-title":"Front Psychiatry"},{"issue":"Suppl 1","key":"R14-20240213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-012-0323-x","article-title":"Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry","volume":"262","author":"Fountoulakis","year":"2012","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R15-20240213","doi-asserted-by":"crossref","first-page":"27527","DOI":"10.1074\/jbc.M701077200","article-title":"ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation machinery to gate induction of protein synthesis-dependent long-term potentiation","volume":"282","author":"Gelinas","year":"2007","journal-title":"J Biol Chem"},{"key":"R16-20240213","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1301254","article-title":"Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium","volume":"32","author":"Gould","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R17-20240213","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbr.2011.04.047","article-title":"Modeling mania: further validation for Black Swiss mice as model animals","volume":"223","author":"Hannah-Poquette","year":"2011","journal-title":"Behav Brain Res"},{"key":"R18-20240213","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-013-3119-4","article-title":"Trehalose induced antidepressant-like effects and autophagy enhancement in mice","volume":"229","author":"Kara","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"R19-20240213","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1017\/neu.2013.23","article-title":"Chronic oral carbamazepine treatment elicits mood stabilizing effects in mice","volume":"26","author":"Kara","year":"2014","journal-title":"Acta Neuropsychiatrica"},{"key":"R20-20240213","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.pharep.2015.02.008","article-title":"Partial effects of the AMPAkine CX717 in a strain specific battery of tests for manic-like behavior in Black Swiss mice","volume":"67","author":"Kara","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"S2","key":"R21-20240213","doi-asserted-by":"crossref","first-page":"S372","DOI":"10.1016\/S0924-977X(16)31316-5","article-title":"Autophagy and affective disorders: conditional deletion of Atg5 gene in mice results in manic-like behavior","volume":"26","author":"Kara","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"R22-20240213","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/j.1875-9114.1997.tb03080.x","article-title":"Sirolimus, a new, potent immunosuppressive agent","volume":"17","author":"Kelly","year":"1997","journal-title":"Pharmacotherapy"},{"key":"R23-20240213","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1176\/appi.ajp.2009.10030434","article-title":"Linking molecules to mood: new insight into the biology of depression","volume":"167","author":"Krishnan","year":"2010","journal-title":"Am J Psychiatry"},{"key":"R24-20240213","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/15622975.2013.830775","article-title":"Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach","volume":"15","author":"Machado-Vieira","year":"2014","journal-title":"World J Biol Psychiatry"},{"key":"R25-20240213","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.mam.2006.08.002","article-title":"Signalling and autophagy regulation in health, aging and disease","volume":"27","author":"Meijer","year":"2006","journal-title":"Mol Aspects Med"},{"key":"R26-20240213","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrn3961","article-title":"Compromised autophagy and neurodegenerative diseases","volume":"16","author":"Menzies","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"R27-20240213","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ki.1996.28","article-title":"The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients","volume":"49","author":"Murgia","year":"1996","journal-title":"Kidney Int"},{"key":"R28-20240213","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/FBP.0b013e32833da5da","article-title":"Intracellular pathways underlying the effects of lithium","volume":"21","author":"Pasquali","year":"2010","journal-title":"Behav Pharmacol"},{"key":"R29-20240213","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1074\/mcp.M900568-MCP200","article-title":"Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor","volume":"9","author":"Pilot-Storck","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"R30-20240213","doi-asserted-by":"crossref","first-page":"e968","DOI":"10.1038\/tp.2016.217","article-title":"IP3 accumulation and\/or inositol depletion: two downstream lithium\u2019s effects that may mediate its behavioral and cellular changes","volume":"6","author":"Sade","year":"2016","journal-title":"Transl Psychiatry"},{"key":"R31-20240213","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1083\/jcb.200504035","article-title":"Lithium induces autophagy by inhibiting inositol monophosphatase","volume":"170","author":"Sarkar","year":"2005","journal-title":"J Cell Biol"},{"key":"R32-20240213","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4161\/auto.2387","article-title":"Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations","volume":"2","author":"Sarkar","year":"2006","journal-title":"Autophagy"},{"key":"R33-20240213","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2014.10.026","article-title":"Environmental enrichment enhances autophagy signaling in the rat hippocampus","volume":"1592","author":"Takahashi","year":"2014","journal-title":"Brain Res"},{"key":"R34-20240213","first-page":"20","article-title":"Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons-dissociation from cholesterol homeostasis","volume":"2011","author":"Zschocke","year":"2011","journal-title":"Neuropsychopharmacology"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201806000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T18:01:44Z","timestamp":1707847304000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201806000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000334","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}